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Colorado became the first state to make laboratory-con-
firmed influenza-associated hospitalizations a case-based 
reportable condition in 2004. We summarized surveillance 
for  influenza  hospitalizations  in  Colorado  during  the  first 
4 recorded influenza seasons (2004–2008). We highlight 
the similarities and differences among influenza seasons; 
no 2 seasons were entirely the same. The 2005–06 influ-
enza season had 2 distinct waves of activity (types A and 
B), the 2006–07 season was substantially later and milder, 
and 2007–08 had substantially greater influenza B activity. 
The case-based surveillance for influenza hospitalizations 
provides information regarding the time course of seasonal 
influenza activity, reported case numbers and population-
based rates by age group and influenza virus type, and a 
measure of relative severity. Influenza hospitalization sur-
veillance provides more information about seasonal influ-
enza activity than any other surveillance measure (e.g., sur-
veillance for influenza-like illness) currently in widespread 
use among states. More states should consider implement-
ing case-based surveillance for influenza hospitalizations.
E
ach  year,  in  the  United  States,  influenza  infections 
cause an estimated 36,000 deaths (1) and >200,000 
hospitalizations (2). The Centers for Disease Control and 
Prevention (CDC) monitors seasonal influenza activity to 
document the timing and geographic spread of influenza 
infection, track influenza related illness in the community, 
monitor the proportion of deaths caused by pneumonia and 
influenza, determine which influenza viruses are circulat-
ing, and identify emerging virus changes (3). Influenza sur-
veillance can also indicate the relative severity of a given 
influenza season compared with previous seasons.
Similarly, state health departments monitor seasonal 
influenza  activity  within  their  jurisdictions  and  contrib-
ute data to CDC. There is little standardization, however, 
among these surveillance systems. All 50 states monitor 
influenza-like illness (ILI) and report these data weekly to 
CDC (L. Brammer, pers. comm.), but other measures of 
influenza activity are conducted only by subsets of states.
In 2004, Colorado became the first state to make influ-
enza-associated hospitalizations a reportable condition and 
part of routine influenza surveillance (4). We summarized 
the first 4 seasons (2004–2008) of case-based surveillance 
for influenza hospitalizations in Colorado.
Methods
Notifiable conditions in Colorado have specified time 
frames for reporting, either within 24 hours or 7 days of 
diagnosis.  Influenza-associated  hospitalizations  must  be 
reported within 7 days. The list of notifiable conditions, 
which includes specified time frames for reporting, is sent 
to acute care hospitals annually. These conditions are re-
ported primarily by hospital infection control practitioners 
and may be reported through the Colorado State Health De-
partment’s web-based electronic disease reporting system   
(CEDRS) or by fax or phone. Colorado has 59 nonfed-
eral acute care hospitals licensed for >25 beds; hospitals 
licensed for <25 beds (as well as some licensed at 25 beds) 
are  critical  access  hospitals  in  rural  areas,  which  infre-
quently diagnose notifiable conditions.
Data from hospitalized patients with influenza report-
ed to CEDRS for the 2004–2008 influenza seasons are ana-
lyzed in this report. Colorado defines an influenza-associat-
ed hospitalization as a hospital admission accompanied by 
a report of an appropriate positive laboratory test result for 
influenza (4). Acceptable and available laboratory tests in 
Colorado are viral culture, reverse transcription–PCR (RT-
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PCR), direct immunofluorescent antibody (DFA) staining, 
and rapid diagnostic tests.
Our analysis defined each influenza season as October 
1 through May 31 of the subsequent year. Week 1 (first 
calendar week) was defined as the week containing Janu-
ary 1 and ending with Saturday of that week. The last week 
(week 52) corresponded to the last full calendar week of the 
year that did not contain January 1 of the subsequent year. 
Specimen collection date was used as a surrogate for date 
of diagnosis (typically the same date for rapid influenza 
testing and DFA) or, if not available, the report date. Time-
liness of reporting was calculated as the difference between 
specimen collection date and entry date in CEDRS.
For all 4 influenza seasons, hospitalizations reported 
early in the season on the basis of rapid tests were not in-
cluded as cases until adequate virologic evidence of circu-
lating influenza virus was demonstrated by testing at the 
state laboratory. Hospitals were requested to submit repeat 
specimens that tested positive by rapid diagnostic tests to 
the state laboratory for confirmatory testing by PCR (viral 
cultures were additionally performed in 2004–05). After 
approximately half of specimens referred in a given week 
were confirmed by RT-PCR, hospitals were informed that 
they no longer needed to refer specimens to the state labo-
ratory; reported hospitalized cases based on positive rapid 
tests were included. The dates for including reported hos-
pitalized cases based on rapid test results occurred during 
weeks  51,  50,  6,  and  48,  respectively,  for  the  2004–05 
through 2007–08 seasons, respectively.
Outpatient surveillance for ILI has been a longstand-
ing component of influenza surveillance at the state and 
national  levels.  CDC  has  suggested  that  states  recruit  a 
minimum of 1 healthcare provider per 250,000 population 
to report weekly the total number of patients seen and the 
number of those patients with ILI. During the influenza 
seasons  included  in  this  analysis,  Colorado’s  volunteer 
provider–to-population ratio ranged from ≈1 provider per 
165,000 persons (2004–05) to 1 provider per 244,000 per-
sons (2007–08 season). The time series from Colorado ILI 
data (5) was qualitatively (timing and relative magnitude of 
peak) compared with that from reported hospitalized influ-
enza cases to provide a measure of validity.
Characteristics of reported influenza hospitalizations 
for  each  season  were  summarized  by  percentages  and 
number of reported influenza hospitalizations. Population 
estimates for 2004–2007 obtained from the Colorado De-
partment of Local Affairs were used to calculate seasonal 
age-specific rates of influenza-associated hospitalization. 
Population  estimates  for  the  first  calendar  year  of  each 
season (e.g., 2004 for the 2004–05 influenza season) were 
used to calculate each season’s rates. Data analysis was 
conducted using SAS version 9.1 (SAS Institute Inc., Cary, 
NC, USA).
Results
Influenza hospitalizations were reported from a mean 
of 44 (range 38–47, 75%) acute care hospitals (licensed for 
>25 beds during the 4 influenza seasons. The 2006–07 sea-
son was notable for having the lowest number of reporting 
hospitals; however, many of these reported substantially 
fewer cases compared with the 3 other seasons. Overall, 
90% (range 86%–92%) of influenza hospitalizations were 
reported within 7 days and 68% (range 64%–71%) were 
reported within 3 days of diagnosis.
The  total  number  of  reported  influenza  hospitaliza-
tions varied somewhat across the 4 seasons as did the dis-
tribution of selected characteristics of the cases (Table 1). 
Similar numbers of influenza cases were reported during 
the 2004–05 (n = 978) and 2007–08 (n = 1,004) seasons; 
slightly lower numbers were reported during the 2005–06 
(n = 848) season. In contrast, only 367 influenza hospital-
izations were reported during the 2006–07 influenza season. 
Similarly, moderate proportions of influenza B hospitaliza-
tions were reported during the 2004–05 and 2005–06 sea-
sons (13% for each); a low proportion (3.3%) of influenza 
B was reported during 2006–07. An unusually high propor-
tion of influenza B (34.2%) was reported among influenza 
hospitalizations during 2007–08.
For 3 of the 4 seasons, the greatest numbers and per-
centages of influenza hospitalizations were among persons 
>80 years of age (Table 1). In contrast, the 2006–07 season 
was noteworthy for lower proportions of cases in the 50–64 
y, 65–79 y, and >80 y age groups, and a higher proportion 
in the 18–49 y age group. By region, overall distributions 
of cases were fairly similar across seasons.
Distribution  of  test  types  was  similar  across  the  4 
seasons. Rapid diagnostic tests were the most frequently 
reported test type (mean 87.3%, range 85.1%– 88.3%) fol-
lowed by viral culture (mean 5.75%, range 4.8%–7.4%) 
and DFA (mean 5.7%, range 4.3%–6.9%). PCR was the 
reported test type for <1.5% of cases in any given season.
The time series of reported influenza hospitalizations 
for each of the 4 seasons (Figure 1) showed that the 2004–
05 and the 2007–08 seasons peaked at almost the same time 
(weeks 7 and 8, respectively) and with similar magnitude. 
However, influenza hospitalizations began to increase sev-
eral weeks earlier during the 2007–08 season with a less 
steep upslope. In contrast, the 2005–06 season appeared to 
have 2 peaks of similar magnitude during weeks 5 and 9, 
and the 2006–07 season exhibited the latest onset (weeks 
3–4) and peak (week 11) and the lowest magnitude. By 
week 15, the time series for all 4 seasons converged at low 
levels of reported hospitalizations.
Compared with the time series from surveillance for 
ILI, the timing of influenza hospitalization peaks was quite 
similar (Table 2). ILI and influenza hospitalizations peaked 
the same week during the 2004–05 and 2007–08 seasons. 
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The 2005–06 season showed 3 peaks for ILI and influenza 
hospitalizations (the first was a minor peak; Figure 1); the 
corresponding time differences were 0, 1, and 2 weeks. 
During the 2006–07 season, ILI peaked 2 weeks earlier 
than influenza hospitalizations. The relative magnitudes of 
peak ILI also corresponded to the relative magnitudes of 
reported influenza hospitalizations; the lowest magnitude 
for each occurred during the 2006–07 season.
The time series of hospitalizations stratified by influen-
za type showed distinctly different patterns among seasons. 
During the 2004–05 season, influenza A and B peaked at 
week 7, although the influenza B proportion was relatively 
small. The 2005–06 season was notable for distinctly sepa-
rate time courses for influenza A and B (i.e., 2 waves of 
activity) with influenza A hospitalizations peaking 5 weeks 
before that for influenza B (Figure 2). The 2006–07 season 







































Figure 1. Hospitalized influenza 
patients  in  Colorado,  USA,  by 
week of diagnosis and influenza 
season.
Table 1. Characteristics of patients hospitalized with influenza, Colorado, USA, 2004–08 influenza seasons* 
Influenza season (October 1–May 31), no. (%) patients 
Characteristics 2004–05 2005–06 2006–07 2007–08
Total recorded cases  978 848 367 1,004
Influenza type 
  A  777 (79.45)  699 (82.43)  345 (94.01)  629 (62.65) 
  B  127 (12.99)  110 (12.97)  12 (3.27)  343 (34.16) 
  Unknown  74 (7.57)  39 (4.60)  10 (2.72)  32 (3.19) 
Age
  <6 mo  64 (6.54)  81 (9.55)  39 (10.63)  79 (7.87) 
  6–23 mo  72 (7.36)  103 (12.15)  46 (12.53)  78 (7.77) 
  2–4 y  56 (5.73)  59 (6.96)  27 (7.36)  65 (6.47) 
  5–17 y  56 (5.73)  72 (8.49)  29 (7.90)  74 (7.37) 
  18–49 y  140 (14.31)  86 (10.14)  78 (21.25)  180 (17.93) 
  50–64 y  149 (15.24)  103 (12.15)  39 (10.63)  142 (14.14) 
  65–79 y  201 (20.55)  169 (19.93)  56 (15.26)  179 (17.83) 
>80 y  240 (24.54)  175 (20.64)  53 (14.44)  207 (20.62) 
Gender 
  M  488 (49.90)  405 (47.76)  186 (50.68)  461 (45.92) 
  F  485 (49.59)  443 (52.24)  180 (49.05)  517 (51.49) 
  Unknown  5 (0.51)  0 (0.00)  1 (0.27)  26 (2.59) 
Region*
  Western Slope  57 (5.83)  100 (11.79)  31 (8.45)  94 (9.36) 
  Northern Front Range  122 (12.47)  108 (12.74)  48 (13.08)  121 (12.05) 
  Denver Metro  550 (56.24)  383 (45.17)  210 (57.22)  520 (51.79) 
  South Central  36 (3.68)  32 (3.77)  8 (2.18)  14 (1.39) 
  San Luis Valley  7 (0.72)  8 (0.94)  12 (3.27)  15 (1.49) 
  Southern Front Range  174 (17.79)  177 (20.87)  48 (13.08)  205 (20.42) 
  Eastern Plains  32 (3.27)  40 (4.72)  10 (2.72)  35 (3.49) 
*Colorado regions can be further divided into counties: Western Slope: Archuleta, Delta, Dolores, Eagle, Garfield, Grand, Gunnison, Hinsdale, Jackson, 
La Plata, Mesa, Moffat, Montezuma, Montrose, Ouray, Pitkin, Rio Blanco, Routt, San Juan, San Miguel, Summit; Northern Front Range: Larimer, Weld; 
Denver Metro: Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas, Jefferson; South Central: Chaffee, Clear Creek, Custer, Fremont, Gilpin, 
Huerfano, Lake, Las Animas, Park, Teller; San Luis Valley: Alamosa, Conejos, Costilla, Mineral, Rio Grande, Saguache; Southern Front Range: El Paso, 
Pueblo, and Eastern Plains: Baca, Bent, Cheyenne, Crowley, Elbert, Kiowa, Kit Carson, Lincoln, Logan, Morgan, Otero, Phillips, Prowers, Sedgwick, 
Washington, Yuma. Case-based surveillance of Influenza Hospitalizations, Colorado
was mild with minimal influenza B activity. The 2007–08 
season was notable for a high proportion of influenza B ac-
tivity, and the time courses for influenza A and B hospital-
izations were superimposed with both peaking at week 8.
When stratified by geographic region, the time series 
of influenza hospitalizations showed peaks that clustered 
within 2 to 3 weeks for 3 of the 4 seasons. During 2005–06, 
however, the Western Slope geographic region (west of the 
Continental Divide) showed a distinct early peak 10 weeks 
before the Denver metropolitan area; other regions peaked 
at varying weeks between peak in Western Slope and peak 
for Denver (Figure 3).
Age  group-specific  rates  of  influenza  hospitaliza-
tions for 3 of the 4 influenza seasons showed character-
istic U-shaped distributions, with rates highest for infants 
<6 months of age and adults >80 years of age (Table 3). 
Because the 2006–07 season was uncharacteristically mild, 
lower rates were seen for all age groups, especially for 
persons >65 years of age, resulting in more of a J-shaped 
distribution. Children 6–23 months of age, for whom in-
fluenza  vaccination  has  been  recommended  since  2004, 
had the third highest age group–specific rate of hospitaliza-
tion during 3 of the 4 seasons (second highest rate during 
2006–07). There was no apparent declining trend across the 
4 seasons in rates of hospitalizations in this age group; in 
fact, rates were similar during 2004–05 and 2007–08; fluc-
tuation during the 2 intervening seasons was wide.
When stratified by influenza type, age group–specif-
ic rates for influenza B hospitalizations were greatest for 
those <6 months and 6–23 months of age during all but the 
2007–08 season. In contrast, the 2007–08 season was note-
worthy for unusually high rates of influenza B, especially 
for persons >80 years of age, but also for persons 60–79 
years of age. For the >80 years age group, rates of influenza 
A and B hospitalizations were almost the same, whereas, 
for infants <6 months of age and children 6–23 months of 
age, rates of influenza A were approximately 3.5–4× higher 
than those for influenza B (Figure 4).
Discussion
This summary of surveillance data from case-based 
reporting of influenza hospitalizations highlights the simi-
larities  and  differences  among  influenza  seasons.  Each 
of several characteristics was fairly similar for 3 of the 4 
seasons presented (not necessarily the same 3), including 
the numbers and time course of hospitalizations and age 
distribution of cases and rates. In contrast, the amount and 
timing  of  influenza  B  activity  demonstrated  substantial 
variability. On the basis of the combination of character-
istics available from reporting of influenza hospitalizations 
though, no 2 seasons were entirely the same; 2005–06 had 
2 distinct waves of activity (types A and B), 2006–07 was 
substantially later and milder, and 2007–08 had substan-
tially greater influenza B activity.
Surveillance for influenza hospitalizations during the 
past 4 seasons in Colorado has substantially added to the 
state health department’s ability to monitor and describe 
seasonal  influenza.  Implementation  and  maintenance  of 
this surveillance activity has been easily absorbed by the 
existing  influenza  surveillance  coordinator  position  and 
has required no additional resources. Approximately 20% 
of the surveillance coordinator’s weekly time is devoted to 
managing and tabulating influenza hospitalization surveil-
lance data. Essential to successful implementation has been 
acceptability  by  hospital  infection  control  practitioners 
statewide, who report almost all of the notifiable diseases 
diagnosed in hospitals in Colorado.
This surveillance component provides more informa-
tion about seasonal influenza activity than any other sur-
veillance measure (e.g., ILI) currently in widespread use 
among states. Influenza hospitalization surveillance pro-
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Table 2. Timing of peak activity for influenza hospitalizations and 
influenza-like illness, Colorado, USA, 2004–08 
Influenza season  (October 1–May 31) 
Category  2004–05 2005–06 2006–07 2007–08
Hospitalizations,
wk 
7 5, 9*  11 8
Influenza-like
illness, wk 
7 52, 4, 11 9 8










































Figure 2. Hospitalized influenza 
patients  in  Colorado,  USA,  by 
week of diagnosis and influenza 
type, 2005–06 season.RESEARCH
vides information regarding the time course (start, peak, 
end) of seasonal influenza activity, including influenza A 
and B; the reported case numbers and population-based 
rates  of  seasonal  influenza  by  influenza  virus  type,  age 
group, gender, and geographic region; and a measure of 
the relative severity of an influenza season compared with 
previous seasons. Some states conduct surveillance for the 
numbers of pneumonia and influenza hospital admissions, 
on a syndromic basis, (6,7) but this may not necessarily 
be population based and only provides information on time 
course and relative severity of influenza activity without 
the additional information available from laboratory-con-
firmed, case-based reporting.
The relative rates of influenza A and B, especially at 
the extremes of age, during 2007–08 were unique among 
the seasons summarized. Influenza A rates were 3.5–4× 
higher than influenza B rates for young infants and young 
children 6 –23 months of age, whereas, for persons >80 
years of age, and to a lesser extent persons 65–79 years of 
age, influenza A and B rates were similar. Since infants <6 
months old are not approved to receive influenza vaccine 
and will not have acquired their own immunity from previ-
ous influenza seasons, their rates of hospitalization related 
to influenza A versus B most closely reflected the epide-
miology of circulating influenza viruses, on the basis of 
prevalence and relative virulence. Low rates of vaccination 
among infants 6–23 months of age (8), for whom influenza 
vaccination has been recommended since 2004, produce 
similar relative rates of influenza A and B as for infants <6 
months old. In contrast, a high proportion of older adults 
receive seasonal influenza vaccine (9), and influenza type-
specific rates of hospitalization in older age groups might 
reflect protection conferred by vaccination with the cur-
rent season’s vaccine and possibly cross-protection from 
previous influenza infection or immunization (10,11). The 
2007–08 influenza vaccine was suboptimally matched to 
circulating viruses, and estimated vaccine efficacy against 
the  predominant  influenza  A  strain  was  58%  compared 
with zero vaccine efficacy against circulating influenza B 
virus (12). Thus, the observed rates of influenza A and B 
hospitalizations for the older age groups during 2007–08 
might reflect partial protection from a moderately effective 
vaccine against the predominant circulating influenza A vi-
rus and no protection from an ineffective vaccine against 
the predominant circulating influenza B virus.
The validity of influenza hospitalization surveillance 
as an indicator of seasonal influenza activity was supported 
by comparison with Colorado ILI surveillance data, which 
showed good agreement. ILI surveillance can be somewhat 
challenging to maintain at the state level due to its reliance 
on providers willing to report data regularly (weekly) for 
which they are not compensated (hence the range of ratios 
for participating provider to population during the 4 sea-
sons included). Although ILI surveillance is a longstanding 
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Table 3. Rates of influenza hospitalizations per 100,000 population, by age group, Colorado, USA, 2004–08 
Influenza season  (October 1–May 31), no. cases/100,000 
Age group  2004–05 2005–06 2006–07 2007–08
<6 mo 185.6 234.6 111.8 225.4
6–23 mo  104.3 148.9 66.0 110.5
2–4 y  27.9 28.4 12.8 30.3
5–17 y  6.7 8.6 3.4 8.5
18–49 y  6.2 3.8 3.4 7.8
50–64 y  19.4 12.8 4.6 16.1
65–79 y  59.4 49.0 15.9 49.5
>80 y  214.4 153.6 45.7 174.5













































Figure 3. Hospitalized influenza 
patients  in  Colorado,  USA,  by 
week  of  diagnosis  and  region, 
2005–06 season.Case-based surveillance of Influenza Hospitalizations, Colorado
component of seasonal influenza surveillance and has been 
heavily promoted by CDC, reports of formal evaluation of 
this surveillance activity are lacking. Colorado hospitalized 
influenza surveillance data also showed fair agreement with 
national summary indicators (timing and relative severity) 
of seasonal influenza for the 4 seasons included. However, 
this is not the most appropriate comparison because nation-
al surveillance data are an aggregate of regional influenza 
outbreaks that typically vary in time course and intensity.
There are several limitations to these data resulting 
from  surveillance  for  influenza-related  hospitalizations. 
First, rapid influenza tests, which were the tests used for 
>85% of the hospitalizations in this report, have subopti-
mal performance characteristics. The sensitivity of rapid 
influenza tests is only moderate, more so among adults than 
children (13,14). This will result in underestimation of the 
true rates of influenza hospitalization, to a greater degree 
for adults than for children, because adults may be admitted 
for influenza-related complications a number of days af-
ter influenza infection when virus is less readily detectible. 
The positive predictive value of influenza rapid tests is low 
(and probability of a false-positive test result is high) when 
the prevalence of circulating influenza virus is low (15), 
which occurs during the early and late parts of the influenza 
season. Use of influenza rapid tests can result in false iden-
tification of the start of seasonal influenza activity based 
on reported hospitalizations and extend the left tail of the 
time series curve. To address this issue, the Colorado state 
health department does not include early season hospital-
ized influenza cases in official case counts or surveillance 
data summaries until the prevalence of circulating influenza 
virus is documented to be adequate based on virologic sur-
veillance by RT-PCR at the state health department labora-
tory (see Methods).
Second, testing practices can affect ascertainment of 
hospitalized influenza cases. This is likely more of an is-
sue for adults among whom exacerbation of underlying 
co-morbidities by influenza might not result in testing for 
influenza at the time of hospital admission. In 1 study in-
volving retrospective medical records review, a low pro-
portion of adults with a discharge diagnosis of pneumonia 
had been tested for influenza (16).
Third, passive public health surveillance of reportable 
diseases is known to be incomplete (17–19). Reporting of 
influenza  hospitalizations  as  part  of  passive,  case-based 
notifiable disease reporting is no exception. Some data on 
completeness of reporting of hospitalized influenza cases 
from the Denver metropolitan area (approximately half the 
state’s population) was available from review of statewide 
hospital discharge data combined with retrospective medi-
cal records review as part of a special multisite enhanced 
influenza  surveillance  project  (20).  During  the  2006–07 
season, completeness of reporting of adult hospitalized pa-
tients with positive test results in the medical record was 
estimated to be 65% (16) and 70% for pediatric cases (Col-
orado Department of Public Health, unpub. data). For the 
2007–08 season, estimated completeness of reporting was 
75% for adult cases and 66% for pediatric cases (Colorado 
Department of Public Health, unpub. data). Thus, it seems 
unlikely that variable completeness of reporting between 
pediatric and adult cases or across seasons is the main factor 
contributing to variation in the relative age group–specific 
rates of hospitalized patients with influenza. Multiple other 
factors that might contribute to the observed epidemiologic 
pattern include virulence of seasonal circulating viruses, 
host immunity from previous seasons, and protection af-
forded by each season’s vaccine.
Despite these limitations that undoubtedly resulted in 
underascertainment of influenza-related hospitalizations, to 
a greater extent for adults than children, surveillance for in-
fluenza hospitalizations can contribute useful information 
for public health monitoring of seasonal influenza activity. 
The numbers of cases and rates derived from passive re-
porting of hospitalized influenza cases should be viewed as 
a minimum estimate, especially for adults. Incomplete case 
ascertainment  and  reporting  should  have  little  effect  on 











































Figure 4. Rates of reported influenza hospital-
izations in Colorado, USA, by age group and 
influenza type, 2007–08 season.RESEARCH
monitoring the time course of hospitalizations for patients 
with influenza. As is true for passive surveillance systems in 
general, assessing the relative severity of a given influenza 
season should still be valid as long as surveillance methods 
and system performance (i.e., completeness of reporting) 
remain relatively unchanged over time.
In conclusion, case-based surveillance for laboratory-
confirmed influenza in hospitalized patients provides mul-
tiple useful population-based measures of seasonal influ-
enza activity that focus on more severe illness attributed 
to influenza. Influenza hospitalization surveillance can also 
contribute to better characterization of the epidemiology 
of influenza across seasons. If more state health depart-
ments implemented case-based surveillance for influenza 
hospitalizations, the aggregated data could comprise a use-
ful contribution to national influenza surveillance. Surveil-
lance for influenza hospitalizations might also contribute to 
state surveillance capacity in preparation for an influenza 
pandemic as well as help target vaccination programs for 
seasonal influenza.
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